CAS 122584-18-3: N-[(2-Bromo-5-hydroxy-4-methoxyphenyl)methyl]-N-[2-(4-hydroxyphenyl)ethyl]formamide

N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide is an anticancer drug that belongs to the class of phenethyl derivatives. It is a radiosensitizer that inhibits DNA and RNA synthesis, leading to cancer cell death. The drug has been shown to have a chiral center and two enantiomers, with the (S)-enantiomer being more active than the (R)-enantiomer. N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide has been shown to be effective in animal models for brain tumors and breast cancer cells. It has also been shown to be effective against leukemia cells, which are resistant to other treatments. N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4